top of page


Probiotic Claims Disputes in Animal Health
A probiotic formulation expert explains how probiotic claims, CFU count discrepancies, strain identification errors, and shelf-life misrepresentation create legal disputes in animal health products and what attorneys need to know when evaluating these cases.


FDA Warning Letters to Pet Supplement Companies Are Increasing: What This Means for Litigation
FDA Is Cracking Down on Pet Supplement Companies In April 2025, the FDA posted warning letters to four pet product companies in a single batch: CBD Dog Health, MycoDog, Bailey’s CBD, and HolistaPet. All four were cited for marketing unapproved new animal drugs — meaning their products made claims that classified them as drugs under the Federal Food, Drug, and Cosmetic Act, but none had obtained FDA approval. This wasn’t an isolated event. In November 2024, FDA issued warning


What Attorneys Should Know About Pet Food Contamination Litigation: A Veterinary Microbiologist’s Perspective
A veterinary microbiologist explains what attorneys need to know about pet food contamination cases, from Salmonella and aflatoxin to manufacturing failures, FDA recall obligations, and how expert witnesses evaluate causation in pet food product liability.


Probiotics Efficacy Disputes
What attorneys need to know about CFU counts, stability claims, and label accuracy before taking on a pet probiotic product liability case.
bottom of page
